SG

In the past six months, Sweetgreen's stock declined by 18.60% between September 22, 2025, and September 18, 2026, reaching a 52-week low of $4.49 on March 29, 2026. More recently, the stock increased by 32.73% in the past month and 10.54% over the last 12 months as of early October 2026, with a year-to-date return of 34.50%. The Q1 2026 earnings report showed declining revenue, negative same-store sales (down 12.8%), and worsening margins. The Q2 2026 earnings report reflected reduced consumer demand due to a multistate cyclosporiasis outbreak, leading to a revised outlook with projected same-store sales drops of 7% to 8% and lowered profit margins, causing shares to fall over 15% on August 7, 2026. The company also removed jalapenos due to a salmonella recall. Despite these challenges, Wells Fargo & Company upgraded Sweetgreen to "overweight" with an $11.00 price objective in late September 2026, and UBS Group upgraded it to "buy" in early August 2026.